B. Kusserow Paul - Feb 17, 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Role: CEO and Chairman of the Board, Director
Signature: /s/ Jennifer R. Guckert, pursuant to a power of attorney
Stock symbol: AMED
Transactions as of: Feb 17, 2022
Transactions value $: -$2,767,304
Form type: 4
Date filed: 2/22/2022, 08:00 PM
Previous filing: Jan 10, 2022
Next filing: Apr 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMED	Common Stock	Options Exercise	$0	+49.1K	+14.04%	$0.00	399K	Feb 17, 2022	Direct	F1
transaction	AMED	Common Stock	Tax liability	-$1.38M	-9.66K	-2.42%	$143.25	389K	Feb 17, 2022	Direct
transaction	AMED	Common Stock	Tax liability	-$1.38M	-9.66K	-2.48%	$143.25	379K	Feb 17, 2022	Direct
holding	AMED	Common Stock						83.8K	Feb 17, 2022	By Trust
holding	AMED	Common Stock						621	Feb 17, 2022	Through 401(k) Plan	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMED	Restricted Stock Units	Options Exercise	$0	-73.6K	-100%	$0.00^*	0	Feb 17, 2022	Common Stock	73.6K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 2, 2019, the Reporting Person was awarded 73,638 performance-based Restricted Stock Units ("RSUs") with vesting based on certification of achievement of identified performance goals for each of fiscal years 2019 through 2021 (1/3 of the RSUs vest, if at all, based on achievement of the 2019 performance goal; 1/3 of the RSUs vest, if at all, based on achievement of the 2020 performance goal; and 1/3 of the RSUs vest, if at all, based on achievement of the 2021 performance goal). The Compensation Committee of the Issuer has certified achievement of the 2019 and 2020 performance measures, but the 2021 performance measure was not satisfied, thereby resulting in the Reporting Person earning 49,092 shares of common stock, which are reported in Table I.
F2	The information in this report is based on a plan statement dated as of December 31, 2021.

Content

On January 2, 2019, the Reporting Person was awarded 73,638 performance-based Restricted Stock Units ("RSUs") with vesting based on certification of achievement of identified performance goals for each of fiscal years 2019 through 2021 (1/3 of the RSUs vest, if at all, based on achievement of the 2019 performance goal; 1/3 of the RSUs vest, if at all, based on achievement of the 2020 performance goal; and 1/3 of the RSUs vest, if at all, based on achievement of the 2021 performance goal). The Compensation Committee of the Issuer has certified achievement of the 2019 and 2020 performance measures, but the 2021 performance measure was not satisfied, thereby resulting in the Reporting Person earning 49,092 shares of common stock, which are reported in Table I.

The information in this report is based on a plan statement dated as of December 31, 2021.

Remarks:

CEO and Chairman of the Board